Diphenhydramine Hydrochloride Price In China

 

  • China: 17060 USD/MT

The price of diphenhydramine hydrochloride in China for Q4 2023 reached 17060 USD/MT in December.

The latest report by IMARC Group, titled "Diphenhydramine Hydrochloride Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data" delivers a comprehensive analysis of Diphenhydramine Hydrochloride prices on a global and regional scale, highlighting the pivotal factors contributing to price changes. This detailed examination includes spot price evaluations at key ports and an analysis of pricing structures, such as Ex Works, FOB, and CIF, across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Diphenhydramine Hydrochloride Prices December 2023:

  • China: 17060 USD/MT

 

Report Offering:

  • Monthly Updates: Annual Subscription
  • Quarterly Updates: Annual Subscription
  • Biannually Updates: Annual Subscription

 

The study delves into the factors affecting Diphenhydramine Hydrochloride price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

 

Request For a Sample Copy of the Report:  https://www.imarcgroup.com/diphenhydramine-hydrochloride-pricing-report/requestsample

 

Diphenhydramine Hydrochloride Price Trend- Q4 2023

The rising prevalence of allergies and sleep disorders worldwide is a key factor driving the market growth of diphenhydramine hydrochloride. Moreover, the increasing awareness of over-the-counter remedies for minor health issues is also a significant growth driver. The pharmaceutical sector, expanding at a swift pace, includes an extensive use of antihistamines such as diphenhydramine hydrochloride, which is significantly contributing to its market growth. Additionally, the shift towards self-medication for minor ailments like common cold and allergies is propelling the demand for this compound. Moreover, the enhancement of pharmaceutical formulations and the development of more effective and faster-acting drugs are bolstering the market growth of diphenhydramine hydrochloride. The increased use of this compound in various therapeutic areas including motion sickness and nighttime sedation further stimulates its market expansion. Personalization and customization in medicinal products, addressing specific patient needs, are trends gaining traction in the healthcare sector. The expansion of applications in both pediatric and geriatric populations is also enhancing the market prospects for Diphenhydramine Hydrochloride. In addition to this, consumer preferences are evolving towards medications that ensure minimal side effects, which supports the development of refined formulations of diphenhydramine hydrochloride. Coupled with this, innovative packaging and presentation in the pharmaceutical industry are contributing significantly to the market appeal and growth of this antihistamine.

Diphenhydramine Hydrochloride Market Analysis

The global diphenhydramine hydrochloride market size reached 60 Thousand Tons in 2023. By 2032, IMARC Group expects the market to reach 80.4 Thousand Tons, at a projected CAGR of 3.30% during 2023-2032. In the fourth quarter of 2023, the North American market for Diphenhydramine Hydrochloride experienced significant volatility, primarily driven by fluctuations in consumer demand, economic policies, and global market conditions. Initially, prices dropped in October due to subdued domestic demand and the presence of ample inventories, compounded by a robust U.S. dollar which made imports more competitive and added to the already high supply levels. However, as consumer spending increased, driven by a decrease in inflation and lower gas prices which eased the financial pressure on consumers, the market witnessed a temporary uplift in prices. This increase reflected a brief surge in consumer confidence despite the persistence of high interest rates, which typically dampen spending on healthcare products. Nonetheless, the resurgence of weak demand from downstream industries, particularly in December, and continued surplus supplies forced another downturn in prices. This seesaw in market dynamics highlights the sensitivity of Diphenhydramine Hydrochloride prices to both domestic economic indicators and broader international trade flows, where the balance of import competition and domestic production capacity plays a crucial role.

Similarly, in the APAC region, Diphenhydramine Hydrochloride prices were influenced by a complex interplay of regional demand shifts, international market access, and local economic conditions. The initial rise in demand within the pharmaceutical and healthcare sectors, especially in China, led to an uptick in prices. This was supported by improved logistics and manufacturing optimism, which bolstered the supply chain and enhanced production capabilities. However, the APAC market also faced challenges such as a contraction in China’s manufacturing sector in October and a decrease in exports, which clouded the otherwise positive outlook. These factors indicate a fragile balance in the APAC market, where external economic pressures and internal production issues can swiftly alter market sentiment and pricing structures. Despite these hurdles, the overall stabilization in the manufacturing sector towards the end of the quarter provided some support to the market, although the persistent weak international demand and logistical challenges continued to pose risks to sustained growth.

 

Browse Full Report: https://www.imarcgroup.com/diphenhydramine-hydrochloride-pricing-report

 

Key Points Covered in the Diphenhydramine Hydrochloride Pricing Report:

The report delivers the following key findings, alongside a comprehensive breakdown of prices by region:

  • Diphenhydramine Hydrochloride Prices
  • Diphenhydramine Hydrochloride Price Chart
  • Diphenhydramine Hydrochloride Demand & Supply
  • Diphenhydramine Hydrochloride Market Analysis
  • Demand Supply Analysis by Type
  • Demand Supply Analysis by Application
  • Demand Supply Analysis of Raw Materials
  • Diphenhydramine Hydrochloride Price Analysis
  • Diphenhydramine Hydrochloride Industry Drivers, Restraints, and Opportunities
  • Diphenhydramine Hydrochloride News and Recent developments
  • Global Event Analysis
  • List of Key Players

 

Regional Price Analysis:

  • Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand.
  • Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece.
  • North America: United States and Canada.
  • Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
  • Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco.

 

Browse More Pricing Reports By IMARC Group:


Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

 

About Us:

IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145